AKAndreas H. Kottmann

Andreas H. Kottmann

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Andreas H. Kottmann has a total of 118 co-authors. Here are the top co-authors by number of shared publications:

  • Lev Starikov

    City University of New York School of Medicine (CSOM), Dept. of Molecular, Cellular and Biomedical Sciences, New York City, NY 10031, USA

    7 shared publications
  • Lauren Malave

    Department of Psychiatry, Columbia University

    4 shared publications
  • Santiago Uribe-Cano

    Department of Molecular, Cellular and Biomedical Sciences, CUNY School of Medicine at City College of New York, City University of New York, New York, NY, USA

    4 shared publications
  • Eitan Friedman

    Department of Molecular, Cellular and Biomedical Sciences, CUNY School of Medicine at City College of New York, City University of New York, New York, USA

    3 shared publications
  • Heike Rebholz

    Institut de Psychiatrie et Neuroscience de Paris

    3 shared publications
  • Santiago Uribe-Cano

    Department of Molecular, Cellular and Biomedical Sciences, CUNY School of Medicine, City University of New York

    3 shared publications

Latest Publications

  • Open Access

    Dopamine 2 receptor ablation from cholinergic neurons attenuates L-DOPA induced dyskinesias

    by Santiago Uribe-Cano, Lauren Malave, Andreas H. Kottmann

    Introduction: L-DOPA-induced dyskinesia (LID) formation requires prominent dopamine oscillations over hours, across years of treatment. Striatal cholinergic interneurons (CIN) have been implicated in both the facilitation and attenuation of LID, but how CIN sense and respond to striatal dopamine levels in this context remains incompletely understood. CIN express both the inhibitory, Gα i -coupled dopamine D2 receptor and the facilitatory, Gα s -coupled dopamine D5 receptor. Although systemic ablation of D5 exacerbates LID, the contribution of CIN-specific D2 expression to LID has not been studied. Methods: We generated mice with conditional ablation of D2 from choline acetyltransferase-expressing cells (D2 ChAT KO) and subjected them to unilateral 6-hydroxydopamine lesions followed by chronic L-DOPA dosing. We assessed dyskinetic behaviors across escalating L-DOPA doses and performed postmortem analyses of LID-associated signaling markers in dorsal striatal CIN. Specifically, we quantified p-ERK expression and phosphorylated rpS6 240/244 , a marker of translational activity, in CIN from mice examined in the L-DOPA ON and OFF states. Results: D2 ChAT KO mice exhibited attenuated LID across escalating L-DOPA doses. Postmortem analyses suggested reduced expression of the LID-associated marker p-ERK among CIN of the dorsal striatum. In control mice, L-DOPA increased phosphorylated rpS6 240/244 in a subset of CIN located in the dorsolateral striatum, indicating increased translational activity during the L-DOPA ON state. Ablation of D2 from CIN prevented this L-DOPA-associated increase in CIN phosphorylated rpS6 240/244 . Discussion: Together, these findings indicate that D2 signaling in CIN promotes LID formation and suggest that CIN D2 is a potential molecular target for mitigating dyskinesias while preserving the therapeutic efficacy of L-DOPA. These results are discussed in the context of recently refined models of how CIN may contribute to aberrant plasticity in the basal ganglia of the Parkinsonian mouse brain.


  • Open Access

    Expression of Angiotensin converting enzyme 2 (ACE2) in the dorsolateral striatum is critical for the temporal coordination of acetylcholine and dopamine, and motor learning.

    by Aria R Walls, Dustin R Zuelke, Andreas H Kottmann

    Neuropeptides are key modulators of adult neurocircuits, balancing their sensitivity to both excitation and inhibition, and fine-tuning fast neurotransmitter action under physiological conditions. We found that the mono-carboxypeptidase angiotensin-converting enzyme 2 (ACE2), which can take part in producing and/or processing of several neuroactive peptides in the mammalian brain and is best known for converting the pro-inflammatory peptide angiotensin II (Ang II) to the stress-ameliorating and neuro-protective peptide angiotensin 1–7 (Ang 1–7), is broadly expressed in the striatum. Cholinergic interneurons (CIN) of the striatum, known to express multiple peptide receptors also co-expressed the corresponding and functionally opposing receptors angiotensin type 1 receptor (AT1R) for Ang II and mas receptor (MasR) for Ang 1–7 . Accordingly, the conditional, semi acute ablation and/or local pharmacological inhibition of ACE2 increased the frequency of acetylcholine (ACh) bursts, reduced the amplitude of dopamine (DA)-modulated pausing of CIN activity, and disrupted the temporal coordination of extracellular levels of ACh and DA during burst events. Further, ablation of ACE2 in the DLS biased directional movement and impaired motor skill learning. Co-injection of the AT1R inhibitor losartan and the dopamine D2 receptor (D2R) agonist quinpirole reduced steady state level cholinergic activity in an additive manner, and proximity ligation supported close spatial association of AT1R and D2R on CINs. Together our study provides evidence that striatal produced ACE2 impinges on the dynamics of ACh and DA and impacts action selection and motor learning through functional and structural interactions of peptidergic and dopaminergic signaling on CIN.

  • Open Access

    The GPCR Smoothened on Cholinergic Interneurons Modulates Dopamine-associated Acetylcholine Dynamics and Affects Learning

    by Santiago Uribe-Cano, Andreas H. Kottmann

    The striatum is a hub for associative learning where fluctuations in dopamine and acetylcholine dynamically regulate behavior. Acetylcholine is released by cholinergic interneurons, which integrate diverse inputs to contextualize dopamine signals and shape behavior. We previously observed that the GPCR Smoothened on cholinergic interneurons suppresses L-DOPA-induced dyskinesias, a motor side-effect resulting from medication elevated dopamine in the Parkinsonian brain. Here, we examine whether Smoothened signaling modulates acetylcholine dynamics, its coordination with dopamine, and motor learning in the healthy brain. We find that cholinergic neuron-specific Smoothened activity bidirectionally modulates acetylcholine inhibition following dopaminergic or cholinergic neuron activity. These effects alter the temporal organization of acetylcholine in the dorsolateral striatum and its coupling to dopamine. Behaviorally, Smoothened ablation from cholinergic neurons promotes motor learning and altered adjustment to changes in the effort or time to obtain reward. These findings identify Smoothened as a bidirectional modulator of striatal dopamine-acetylcholine coordination and striatal learning. Highlights: Sonic Hedgehog–Smoothened signaling in striatal cholinergic interneurons bidirectionally regulates dopamine-associated cholinergic pauses without altering dopamine release. Cholinergic Smoothened shapes the timing, duration, and coordination of endogenous dopamine–acetylcholine dynamics in the dorsolateral striatum. Cholinergic Smoothened modulates striatal learning by accelerating motor learning while constraining effort management in an instrumental task. Graphical


  • Open Access

    Lateral Motor Column specific expression of Sonic Hedgehog contributes to maintenance and scaling of pMN progenitor cell populations during oligodendrogenesis

    by Andreas Kottmann, Lev Starikov, Miruna Ghinia-Tegla

    Motor neurons (MNs) and oligodendrocyte precursor cells (OPCs) emerge sequentially from the pMN precursor domain during spinal cord development. MNs diversify into muscle specific subtypes and settle in stereotypic locations in the ventral horns. In contrast, OPCs are mobile and appear to evenly populate the parenchyma. Whether earlier born MNs influence OPC production is controversial. We found that Sonic Hedgehog signaling emanating from nascent MNs of the lateral motor column is critical for maintaining a larger and more yielding pMN domain at limb levels compared to trunk levels during OPC production. Reduced Shh signaling resulted in unrecoverable diminishment of pMN domain based OPC production leaving the spinal cord impoverished of OPC. Our results suggest that production of OPC at limb levels is contingent on completion of MN production.

  • Open Access

    Dopamine 2 receptor ablation from cholinergic neurons attenuates L-DOPA induced dyskinesias

    by Santiago Uribe-Cano, Lauren Malave, Andreas H. Kottmann

    Striatal cholinergic interneurons (CIN) have been implicated in both, the facilitation as well as the attenuation of L-DOPA-induced dyskinesias (LID). These findings indicate that CIN impinge on formation and expression of LID in a dopamine state dependent manner since LID formation requires prominent oscillations of dopamine at timescales of hours over several years. However, how CIN sense and interpret striatal dopamine levels is not completely understood. CIN express both inhibitory, high affinity, Gαi coupled D2 (D2R)- and facilitatory, medium affinity, Gαs coupled D5 (D5R)-dopamine receptors. While the systemic ablation of D5R exacerbates LID, the contribution of D2R expression in CIN to LID has not been studied. Here, we produced mice with conditional ablation of D2R from choline acetyltransferase–expressing cells (D2 ChAT KO) subjected to unilateral 6-hydroxydopamine lesions and chronic L-DOPA dosing. Behavioral assessments revealed that D2 ChAT KO mice exhibited attenuated LID across escalating L-DOPA doses. Postmortem analyses showed reduced expression of the LID-associated marker p-ERK in CIN in the dorsolateral striatum. Further, quantification of the CIN activity marker p-rpS6 240/244 of mice in the L-DOPA ON and OFF state revealed that L-DOPA resulted in an increase of cholinergic activity driven by a subset of mainly dorso-laterally located CIN. D2R ablation from CIN prevented the L-DOPA associated increase in cholinergic activity. Together, these findings indicate that D2R signaling in CIN promotes LID formation, and they highlight CIN D2R as a potential molecular target for mitigating dyskinesias while preserving the therapeutic efficacy of L-DOPA. We discuss our results in the context of recently refined models how CIN contribute to aberrant plasticity in the basal ganglia of mouse models of Parkinson’s Disease.

  • Open Access

    Dopaminergic co-transmission with sonic hedgehog inhibits abnormal involuntary movements in models of Parkinson’s disease and L-Dopa induced dyskinesia

    by Lauren Malave, Dustin R. Zuelke, Santiago Uribe-Cano, Lev Starikov, Heike Rebholz, Eitan Friedman, Chuan Qin, Qin Li, Erwan Bezard, Andreas H. Kottmann

    L-Dopa induced dyskinesia (LID) is a debilitating side effect of dopamine replacement therapy for Parkinson’s Disease. The mechanistic underpinnings of LID remain obscure. Here we report that diminished sonic hedgehog (Shh) signaling in the basal ganglia caused by the degeneration of midbrain dopamine neurons facilitates the formation and expression of LID. We find that the pharmacological activation of Smoothened, a downstream effector of Shh, attenuates LID in the neurotoxic 6-OHDA- and genetic aphakia mouse models of Parkinson’s Disease. Employing conditional genetic loss-of-function approaches, we show that reducing Shh secretion from dopamine neurons or Smoothened activity in cholinergic interneurons promotes LID. Conversely, the selective expression of constitutively active Smoothened in cholinergic interneurons is sufficient to render the sensitized aphakia model of Parkinson’s Disease resistant to LID. Furthermore, acute depletion of Shh from dopamine neurons through prolonged optogenetic stimulation in otherwise intact mice and in the absence of L-Dopa produces LID-like involuntary movements. These findings indicate that augmenting Shh signaling in the L-Dopa treated brain may be a promising therapeutic approach for mitigating the dyskinetic side effects of long-term treatment with L-Dopa.


  • Open Access

    Publisher Correction: The Dopamine D5 receptor contributes to activation of cholinergic interneurons during L-DOPA induced dyskinesia

    by Julia Castello, Marisol Cortés, Lauren Malave, Andreas Kottmann, David R. Sibley, Eitan Friedman, Heike Rebholz

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.